GSK press releases Follow GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development GSK announced that it has licensed its M72/AS01E3 tuberculosis disease (TB) vaccine. https://www.gsk.com/en-gb/media/press-releases/gsk-licenses-tuberculosis-vaccine-candidate-to-the-bill-melinda-gates-medical-research-institute-for-continued-development/ gsk.com
